Related Experiment Video
Updated: Apr 16, 2026
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Seek and destroy: relating cancer drivers to therapies
Emmanuel Martinez-Ledesma1, John F de Groot2, Roel G W Verhaak3
1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
In this issue of Cancer Cell, Rubio-Perez and colleagues present an in silico prescription strategy based on identifying somatic driver alterations and druggability options. Although relatively few patients were found treatable following current clinical guidelines, many more could benefit from drug repurposing, considering compounds at various stages of (pre-)clinical investigation.
Insights
This study introduces a computational strategy to identify cancer drug targets. While current treatments are limited, drug repurposing offers new therapeutic options for more patients.
Area of Science:
- Oncology
- Computational Biology
- Pharmacology
Background:
- Identifying actionable targets in cancer is crucial for effective treatment.
- Current clinical guidelines may not cover all potential therapeutic strategies for cancer patients.
Purpose of the Study:
- To develop an in silico (computational) prescription strategy for cancer treatment.
- To identify somatic driver alterations and assess their druggability.
- To explore drug repurposing opportunities for a broader patient benefit.
Main Methods:
- Utilized computational methods to analyze cancer genomes.
- Identified somatic driver alterations in patient tumors.
- Assessed the druggability of identified alterations using existing and investigational compounds.
Main Results:
- A limited number of patients were identified as treatable under current clinical guidelines.
- The strategy revealed a significant number of patients could potentially benefit from repurposed drugs.
- Compounds in various stages of clinical development showed promise for drug repurposing.
Conclusions:
- In silico drug prescription strategies can identify novel therapeutic avenues.
- Drug repurposing holds significant potential to expand treatment options for cancer patients.
- Further investigation into drug repurposing is warranted to maximize patient benefit.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:18Cancer